Naloxegol is indicated for the treatment of opioid-induced constipation in patients with chronic non-cancer pain. It is also known as Movantik and Moventig. Reference standards of Naloxegol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Naloxegol - API Standards
[catalogue_number] => PA 14 77000
[category_ids] => ,80,78,70,82,
[chemical_name] =>
[weight] => 651.78
[form] => C34H53NO11
[cas] => 854601-70-0
[pslug] => 854601-70-0-naloxegol-api-pa1477000
[latest_product] => 0
[linkproducts] => 1
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
stdClass Object
(
[pname] => (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17,20-Heptaoxadocosan-22-yl)oxy)-3-nitroso-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
[catalogue_number] => PA 14 0771000
[category_ids] => ,70,78,80,82,162,
[chemical_name] =>
[weight] => 640.73
[form] => C31H48N2O12
[cas] => NA
[pslug] => 4r-4as-7s-7ar-12bs-7-2-5-8-11-14-17-20-heptaoxadocosan-22-yl-oxy-3-nitroso-1-2-3-4-5-6-7-7a-octahydro-4ah-4-12-methanobenzofuro-3-2-e-isoquinoline-4a-9-diol-pa140771000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)